177 related articles for article (PubMed ID: 27398153)
1. Buformin exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells.
Kilgore J; Jackson AL; Clark LH; Guo H; Zhang L; Jones HM; Gilliam TP; Gehrig PA; Zhou C; Bae-Jump VL
Am J Transl Res; 2016; 8(6):2705-15. PubMed ID: 27398153
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer.
Schointuch MN; Gilliam TP; Stine JE; Han X; Zhou C; Gehrig PA; Kim K; Bae-Jump VL
Gynecol Oncol; 2014 Aug; 134(2):346-55. PubMed ID: 24880141
[TBL] [Abstract][Full Text] [Related]
3. Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway.
Hanna RK; Zhou C; Malloy KM; Sun L; Zhong Y; Gehrig PA; Bae-Jump VL
Gynecol Oncol; 2012 May; 125(2):458-69. PubMed ID: 22252099
[TBL] [Abstract][Full Text] [Related]
4. The Effects of NT-1044, a Novel AMPK Activator, on Endometrial Cancer Cell Proliferation, Apoptosis, Cell Stress and
Roque DR; Zhang L; Wysham WZ; Han J; Sun W; Yin Y; Livingston JN; Batchelor KW; Zhou C; Bae-Jump VL
Front Oncol; 2021; 11():690435. PubMed ID: 34422646
[TBL] [Abstract][Full Text] [Related]
5. Buformin suppresses proliferation and invasion via AMPK/S6 pathway in cervical cancer and synergizes with paclitaxel.
Li J; Chen L; Liu Q; Tang M; Wang Y; Yu J
Cancer Biol Ther; 2018 Jun; 19(6):507-517. PubMed ID: 29400636
[TBL] [Abstract][Full Text] [Related]
6. Effects of Fatty Acid Synthase Inhibition by Orlistat on Proliferation of Endometrial Cancer Cell Lines.
Wysham WZ; Roque DR; Han J; Zhang L; Guo H; Gehrig PA; Zhou C; Bae-Jump VL
Target Oncol; 2016 Dec; 11(6):763-769. PubMed ID: 27188391
[TBL] [Abstract][Full Text] [Related]
7. Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy.
Cantrell LA; Zhou C; Mendivil A; Malloy KM; Gehrig PA; Bae-Jump VL
Gynecol Oncol; 2010 Jan; 116(1):92-8. PubMed ID: 19822355
[TBL] [Abstract][Full Text] [Related]
8. Combination simvastatin and metformin synergistically inhibits endometrial cancer cell growth.
Kim JS; Turbov J; Rosales R; Thaete LG; Rodriguez GC
Gynecol Oncol; 2019 Aug; 154(2):432-440. PubMed ID: 31178149
[TBL] [Abstract][Full Text] [Related]
9. Buformin suppresses osteosarcoma via targeting AMPK signaling pathway.
Ding Y; Lv S; Li G; Cui J; Chen Y
Open Life Sci; 2020; 15(1):409-417. PubMed ID: 33817229
[TBL] [Abstract][Full Text] [Related]
10. Metformin targeting autophagy overcomes progesterone resistance in endometrial carcinoma.
Zhuo Z; Wang A; Yu H
Arch Gynecol Obstet; 2016 Nov; 294(5):1055-1061. PubMed ID: 27402506
[TBL] [Abstract][Full Text] [Related]
11. Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling.
Han J; Zhang L; Guo H; Wysham WZ; Roque DR; Willson AK; Sheng X; Zhou C; Bae-Jump VL
Gynecol Oncol; 2015 Sep; 138(3):668-75. PubMed ID: 26135947
[TBL] [Abstract][Full Text] [Related]
12. Reversal of obesity-driven aggressiveness of endometrial cancer by metformin.
Guo H; Kong W; Zhang L; Han J; Clark LH; Yin Y; Fang Z; Sun W; Wang J; Gilliam TP; Lee D; Makowski L; Zhou C; Bae-Jump VL
Am J Cancer Res; 2019; 9(10):2170-2193. PubMed ID: 31720081
[TBL] [Abstract][Full Text] [Related]
13. Metformin Exhibits an Attractive Antineoplastic Effect on Human Endometrial Cancer by Regulating the Hippo Signaling Pathway.
Wang M; Zhang Q; Li Y; Jin L; Fang Z
J Oncol; 2022; 2022():5824617. PubMed ID: 36226249
[TBL] [Abstract][Full Text] [Related]
14. [Research of the influence and mechanism about metformin on the proliferation of differentiated endometrial carcinoma cells].
Wang J; Shi H; Xie Y; Peng Z
Zhonghua Fu Chan Ke Za Zhi; 2015 Sep; 50(9):685-91. PubMed ID: 26675396
[TBL] [Abstract][Full Text] [Related]
15. Novasoy and genistein inhibit endometrial cancer cell proliferation through disruption of the AKT/mTOR and MAPK signaling pathways.
Malloy KM; Wang J; Clark LH; Fang Z; Sun W; Yin Y; Kong W; Zhou C; Bae-Jump VL
Am J Transl Res; 2018; 10(3):784-795. PubMed ID: 29636868
[TBL] [Abstract][Full Text] [Related]
16. Metformin impairs growth of endometrial cancer cells via cell cycle arrest and concomitant autophagy and apoptosis.
Takahashi A; Kimura F; Yamanaka A; Takebayashi A; Kita N; Takahashi K; Murakami T
Cancer Cell Int; 2014; 14():53. PubMed ID: 24966801
[TBL] [Abstract][Full Text] [Related]
17. Phenformin has anti-tumorigenic effects in human ovarian cancer cells and in an orthotopic mouse model of serous ovarian cancer.
Jackson AL; Sun W; Kilgore J; Guo H; Fang Z; Yin Y; Jones HM; Gilliam TP; Zhou C; Bae-Jump VL
Oncotarget; 2017 Nov; 8(59):100113-100127. PubMed ID: 29245964
[TBL] [Abstract][Full Text] [Related]
18. Metformin inhibits proliferation and migration of endometrial cancer cells through regulating PI3K/AKT/MDM2 pathway.
Qiang P; Shao Y; Sun YP; Zhang J; Chen LJ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1778-1785. PubMed ID: 30840303
[TBL] [Abstract][Full Text] [Related]
19. [Effects of metformin on the estrogen-induced proliferation and the expression of ER in human endometrial cancer cells].
Zhang J; Zhang B; Yin Z; Chen F; Liu T; Xu H; Liu Y; Zhou X
Zhonghua Fu Chan Ke Za Zhi; 2014 Dec; 49(12):932-7. PubMed ID: 25608995
[TBL] [Abstract][Full Text] [Related]
20. Effects of metformin, buformin, and phenformin on the post-initiation stage of chemically induced mammary carcinogenesis in the rat.
Zhu Z; Jiang W; Thompson MD; Echeverria D; McGinley JN; Thompson HJ
Cancer Prev Res (Phila); 2015 Jun; 8(6):518-27. PubMed ID: 25804611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
